Skip to main content

Table 1 Demografic and spirometric data patients with IPF and sarcoidosis

From: Circulating concentration of markers of angiogenic activity in patients with sarcoidosis and idiopathic pulmonary fibrosis

 

Sarcoidosis total

IPF

Controls

N = 43 (20 F/ 23 M)

N = 17 (7 F/ 10 M)

N = 20 (10 F/10 M)

(mean ± SEM)

(mean ± SEM)

(mean ± SEM)

Median (Interquartile range)

Median (Interquartile range)

Median (Interquartile range)

Age (years)

   

35.7 ± 1.3

58.3 ± 1.6 ***

34.3 ± 1.2

33.5 (29.5–40.0)

58.0 (53.7–64.0)

33.5 (29.5–37.5)

BMI (kg/m2)

26.9 ± 0.5

27.4 ± 0.7

27.2 ± 0.6

27.0 (23.2–31.4)

27.6 (21.2–31.3)

27.1 (22.3–30.1)

FEV1 (% of predicted)

   

86.1 ± 1.6

67.9 ± 2.3 **

 

85.5 (81.0–93.0)

69.0 (61.0–77.3)

 

FVC (% of predicted)

   

96.2 ± 2.1

70.3 ± 1.8 **

 

98.0 (88.5–104.0)

69.0 (63.5–79.0)

 

FEV1%VC (%)

   

75.7 1.0

77.0 ± 1.8

 

75.0 (71.0–80.0)

76 (73.5–82.3)

 
  1. F females, M males, IPF idiopathic pulmonary fibrosis, FEV1 Forced expiratory volume in 1 s
  2. FVC Forced Vital Capacity, FEV1%VC forced expiratory volume in one second % of vital capacity **p < 0.001 IPF vs sarcoidosis ***p < 0.001 IPF vs controls and sarcoidosis
Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us